Ju ST - Search Results

1

FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3.

Xiao S, Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Widom RL, Ju ST. Xiao S, et al. Among authors: ju st. Eur J Immunol. 1999 Nov;29(11):3456-65. doi: 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.0.CO;2-B. Eur J Immunol. 1999. PMID: 10556800 Free article.

2

Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.

Xiao S, Zhang X, Mann KK, Jodo S, Li L, Jarjour WN, Marshak-Rothstein A, Sherr DH, Ju ST. Xiao S, et al. Among authors: ju st. Int Immunol. 2004 May;16(5):759-66. doi: 10.1093/intimm/dxh078. Epub 2004 Apr 13. Int Immunol. 2004. PMID: 15096479

3

Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.

Cui H, Sherr DH, el-Khatib M, Matsui K, Panka DJ, Marshak-Rothstein A, Ju ST. Cui H, et al. Among authors: ju st. Cell Immunol. 1996 Feb 1;167(2):276-84. doi: 10.1006/cimm.1996.0036. Cell Immunol. 1996. PMID: 8603437 Free article.

4

Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation.

Cui H, el-Khatib M, Sherr DH, Ettinger R, Sy MS, Marshak-Rothstein A, Ju ST. Cui H, et al. Among authors: ju st. Cell Immunol. 1996 Feb 1;167(2):302-12. doi: 10.1006/cimm.1996.0039. Cell Immunol. 1996. PMID: 8603440 Free article.

5

Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses.

Ozdemirli M, El-Khatib M, Foote LC, Wang JK, Marshak-Rothstein A, Rothstein TL, Ju ST. Ozdemirli M, et al. Among authors: ju st. Eur J Immunol. 1996 Feb;26(2):415-9. doi: 10.1002/eji.1830260222. Eur J Immunol. 1996. PMID: 8617312

6

CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.

Wang JK, Zhu B, Ju ST, Tschopp J, Marshak-Rothstein A. Wang JK, et al. Among authors: ju st. Cell Immunol. 1997 Aug 1;179(2):153-64. doi: 10.1006/cimm.1997.1159. Cell Immunol. 1997. PMID: 9268499 Free article.

7

Proteasome regulation of Fas ligand cytotoxicity.

Matsui K, Omura S, Cui H, Schauer SL, Sonenshein GE, Ju ST. Matsui K, et al. Among authors: ju st. Eur J Immunol. 1997 Sep;27(9):2269-78. doi: 10.1002/eji.1830270922. Eur J Immunol. 1997. PMID: 9341769

8

Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.

Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST. Matsui K, et al. Among authors: ju st. J Immunol. 1998 Oct 1;161(7):3469-73. J Immunol. 1998. PMID: 9759866

9

Hypothesis: A recurrent, moderate activation fosters systemic autoimmunity--the apoptotic roles of TCR, IL-2 and Fas ligand.

Matsui K, Jodo S, Xiao S, Ju ST. Matsui K, et al. Among authors: ju st. J Biomed Sci. 1999 Sep-Oct;6(5):306-13. doi: 10.1007/BF02253519. J Biomed Sci. 1999. PMID: 10494037 Review.

10

Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.

Ju ST, Matsui K, Ozdemirli M. Ju ST, et al. Int Rev Immunol. 1999;18(5-6):485-513. doi: 10.3109/08830189909088495. Int Rev Immunol. 1999. PMID: 10672498 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters